Fig. 1: Clinical outcomes following allo-HCT in patients not in complete remission (CR). | Blood Cancer Journal

Fig. 1: Clinical outcomes following allo-HCT in patients not in complete remission (CR).

From: Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohort

Fig. 1

Overall survival (OS) analysis: A OS of the entire cohort; B OS stratified by disease category; C OS stratified by the presence of circulating blasts; D OS stratified by recipient CMV serostatus; E cumulative incidence of relapse, stratified by disease categories; F non-relapse mortality (NRM); G incidence of acute graft-versus-host disease (GVHD) grades II–IV; H incidence of acute graft-versus-host disease (GVHD) grades III–IV.

Back to article page